ESIRA, a novel framework integrating efficacy and safety for evaluating first-line treatments in advanced hepatocellular carcinoma

Key Points

• Efficacy and safety improvements in hepatocellular carcinoma treatments were identified using the ESIRA framework, enhancing evaluation methods.
• The ESIRA framework integrates multiple assessment metrics, enabling a comprehensive overview of treatment effectiveness and patient safety.
• Analysis incorporates both efficacy and safety data, creating a balanced approach to evaluate first-line treatments and their outcomes.
• Supports the need for innovative frameworks in oncology to accommodate the complexities of treatment evaluation and patient care.